Astrazeneca (AZN) EBT (2009 - 2026)
Astrazeneca (AZN) posted quarterly EBT of $2.9 billion for Q2 2026, down 18.64% year-over-year from $3.6 billion in Q2 2025, and down 26.06% quarter-over-quarter from $3.9 billion in Q1 2026.
Astrazeneca (AZN) EBT (2009 - 2026) Analysis & Trends
Astrazeneca's EBT history runs 18 years deep, the most recent figure standing at $2.9 billion for Q2 2026.
- In Q2 2026, EBT fell 18.64% year-over-year to $2.9 billion; the TTM figure through Jun 2026 stood at $12.7 billion (up 21.31% YoY), while the FY2025 annual figure was $12.9 billion, up 48.84% from the prior year.
- EBT for Q2 2026 stood at $2.9 billion, down from $3.9 billion in the prior quarter.
- The five-year high for EBT was $6.0 billion in Q4 2023, with the low at $247.0 million in Q2 2022.
- The 5-year median for EBT is $2.3 billion (2023), against an average of $2.4 billion.
- The sharpest annual moves came in 2023 and 2024: EBT jumped 745.34% in 2023, then tumbled 72.24% in 2024.
- Astrazeneca's EBT stood at $778.0 million in 2022, then surged by 671.47% to $6.0 billion in 2023, then sank by 72.24% to $1.7 billion in 2024, then jumped by 57.8% to $2.6 billion in 2025, then increased by 10.08% to $2.9 billion in 2026.
- Business Quant data shows AZN's EBT at $2.9 billion in Q2 2026, $3.9 billion in Q1 2026, and $2.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 17.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.89 Bn |
| Mar 31, 2026 | 3.91 Bn |
| Dec 31, 2025 | 2.63 Bn |
| Sep 30, 2025 | 3.24 Bn |
| Jun 30, 2025 | 3.56 Bn |
| Mar 31, 2025 | 3.40 Bn |
| Dec 31, 2024 | 1.67 Bn |
| Sep 30, 2024 | 1.83 Bn |
| Jun 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 6.00 Bn |
| Sep 30, 2023 | 1.65 Bn |
| Jun 30, 2023 | 2.09 Bn |
| Mar 31, 2023 | 2.26 Bn |
| Dec 31, 2022 | 778.00 Mn |
| Sep 30, 2022 | 922.00 Mn |
| Jun 30, 2022 | 247.00 Mn |
| Mar 31, 2022 | 553.00 Mn |
| Dec 31, 2021 | -636.00 Mn |
| Sep 30, 2021 | -2.00 Bn |